Skip to main content
Kudos

Explore subjects

All stories
  • Arts and humanities
  • Business and management
  • Environmental research
  • Life sciences
  • Medical research
  • Physical sciences
  • Social sciences
  • Technology and engineering
  • About Kudos

  • Publishers
  • Pharma
  • Institutions and universities
  • Individual researchers and groups

  • Welcome pack and guides
  • Webinars and courses
  • Blog and news

  • Search Kudos

    Main menu

  • Home
  • Showcases on Kudos

  • What's new
  • Support
  • Log in
  • Sign up free
  • Discover

  • Showcases on Kudos
  • Subjects on Kudos

  • Arts and humanities
  • Business and management
  • Environmental research
  • Life sciences
  • Medical research
  • Physical sciences
  • Social sciences
  • Technology and engineering
  • Services and resources

  • About Kudos

  • Publishers
  • Pharma
  • Institutions and universities
  • Individual researchers and groups

  • Welcome pack and guides
  • Webinars and courses
  • Blog and news
  • Admin

    Log in Sign up free
    Celaletdin Camci's profile pictureCC

    Celaletdin Camci

    5 Stories

    All Stories

    1. Polymorphisms in the MTHFR gene are associated with recurrence risk in lymph node-positive breast cancer patients

      Article • OncoTargets and Therapy, September 2016, Dove Medical Press

      Celaletdin Camci

    2. Polymorphism of CYP3A4 and ABCB1 genes increase the risk of neuropathy in breast cancer patients treated with paclitaxel and docetaxel

      Article • OncoTargets and Therapy, August 2016, Dove Medical Press

      Celaletdin Camci, Abdullah Tuncay Demiryürek

    3. Survival analysis in second-line and third-line chemotherapy with irinotecan followed by topotecan or topotecan followed by irinotecan for extensive-stage small-cell lung cancer patients: a single-center retrospective study

      Article • OncoTargets and Therapy, April 2016, Dove Medical Press

      Celaletdin Camci

    4. Prognostic impact of initial maximum standardized uptake value of 18F-FDG PET/CT on treatment response in patients with metastatic lung adenocarcinoma treated with erlotinib

      Article • OncoTargets and Therapy, December 2015, Dove Medical Press

      Celaletdin Camci, Cemil Oktay

    5. Could erlotinib treatment lead to acute cardiovascular events in patients with lung adenocarcinoma after chemotherapy failure?

      Article • OncoTargets and Therapy, June 2015, Dove Medical Press

      Celaletdin Camci

    Kudos
    • For researchers
    • For publishers
    • For universities
    • For pharma
    • For research groups
    • Research showcase
    • About Kudos
    • News
    • Careers
    • Engineering blog
    • Service status
    • User guide
    • Content and resources
    • FAQs
    • Contact us
    • Terms & conditions
    • Privacy policy
    • Cookie policy

    © 2026 Kudos Innovations Ltd. Kudos is registered in England – Registration No. 08642156. Registered Office: Kudos Innovations Ltd, 100 Liverpool Street, London, EC2M 2AT, UK